Evidence map›Paper›PMID 31516842›Full record

ArticleToxicology reports2019

Synthesis and exploration of a novel chlorobenzylated 2-aminothiazole-phenyltriazole hybrid as migratory inhibitor of B16F10 in melanoma cells.

Muhammad Athar Abbasi, Seon-Mi Yu, Aziz-Ur-Rehman, Sabahat Zahra Siddiqui, Song Ja Kim, Hussain Raza, Mubashir Hassan, Abdul Rehman Sadiq Butt, Syed Anan Ali Shah, Sung-Yum Seo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Muhammad Athar AbbasiCollege of Natural Sciences, Department of Biological Sciences, Kongju National University, Gongju, 32588, South Korea.
Seon-Mi YuCollege of Natural Sciences, Department of Biological Sciences, Kongju National University, Gongju, 32588, South Korea.
Aziz-Ur-RehmanDepartment of Chemistry, Government College University, Lahore, 54000, Pakistan.
Sabahat Zahra SiddiquiDepartment of Chemistry, Government College University, Lahore, 54000, Pakistan.
Song Ja KimCollege of Natural Sciences, Department of Biological Sciences, Kongju National University, Gongju, 32588, South Korea.
Hussain RazaCollege of Natural Sciences, Department of Biological Sciences, Kongju National University, Gongju, 32588, South Korea.
Mubashir HassanInstitute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan.
Abdul Rehman Sadiq ButtDepartment of Chemistry, Government College University, Lahore, 54000, Pakistan.
Syed Anan Ali ShahFaculty of Pharmacy and Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA, Cawangan Selangor Kampus, Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.
Sung-Yum SeoCollege of Natural Sciences, Department of Biological Sciences, Kongju National University, Gongju, 32588, South Korea.
Kongju National University · KRGovernment College University, Lahore · PKUniversiti Teknologi MARA · MYUniversity of Lahore · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the study presented here, a novel chlorobenzylated bi-heterocyclic hybrid molecule (

Indexed as

2-AminothiazoleAnti-proliferationMatrix metalloproteinaseTriazoleZymography

Identifiers

PMID31516842
PMCPMC6727243
OpenAlexW2970141699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.